{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:52Z","timestamp":1793066332098,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271436"],"award-info":[{"award-number":["82271436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH190"],"award-info":[{"award-number":["ZR2022MH190"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan\u00a0Young\u00a0Scholar\u00a0Program","award":["qnts202306347"],"award-info":[{"award-number":["qnts202306347"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The <jats:italic>POMT2<\/jats:italic> gene, which encodes protein O-mannosyltransferase 2, is essential for \u03b1-dystroglycan glycosylation. Variants in <jats:italic>POMT2<\/jats:italic> cause various disorders, including the relatively rare presentation of limb-girdle muscular dystrophy R14 (LGMDR14).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study retrospectively analyzed the clinical, pathological, and genetic data of three LGMDR14 patients. And we investigated the pathogenic mechanisms of <jats:italic>POMT2<\/jats:italic> variants through aberrant mRNA processing analysis and molecular dynamics simulations to assess their impact on protein structure and function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We recruited three LGMDR14 patients from unrelated Chinese families, all presenting with adult-onset proximal muscle weakness. All of these patients showed a myopathic pattern on electromyography and decreased \u03b1-dystroglycan expression on muscle biopsy. One patient had severe cardiomyopathy and mild cognitive impairment. Genetic sequencing revealed compound heterozygous variants in the <jats:italic>POMT2<\/jats:italic> gene in all three patients: c.1006\u2009+\u20091G\u2009&gt;\u2009A and c.295\u00a0C\u2009&gt;\u2009T in patient 1, c.1261\u00a0C\u2009&gt;\u2009T and c.700_701insCT in patient 2, and c.812\u00a0C\u2009&gt;\u2009T and c.170G\u2009&gt;\u2009A in patient 3. Variants c.700_701insCT, c.812\u00a0C\u2009&gt;\u2009T, and c.170G\u2009&gt;\u2009A are novel. Splicing and cDNA analysis revealed that the c.1006\u2009+\u20091G\u2009&gt;\u2009A variant could cause retention of the first 26\u00a0bp of intron 8 by inducing recognition of new donor splice sites. Pyrosequencing revealed that both frameshift variant c.700_701insCT and splicing variant c.1006\u2009+\u20091G\u2009&gt;\u2009A triggered a nonsense-mediated mRNA decay. Molecular dynamics indicated that c.1006\u2009+\u20091G\u2009&gt;\u2009A, c.700_701insCT, and c.170G\u2009&gt;\u2009A variants could lead to truncated proteins, altering stability and function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our study summarizes the clinical, pathological and genetic characteristics of three adult-onset LGMDR14 patients, expanding the genetic spectrum of <jats:italic>POMT2<\/jats:italic> variants. Moreover, the finding reinforces the impact of <jats:italic>POMT2<\/jats:italic> splicing defects on mRNA regulation, and molecular dynamics simulations predict the structural consequences of <jats:italic>POMT2<\/jats:italic> variants, providing additional evidence for their functional effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03578-7","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:43:32Z","timestamp":1742301812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel POMT2 variants associated with limb-girdle muscular dystrophy R14: genetic, histological and functional studies"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1952-7031","authenticated-orcid":false,"given":"Guiguan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"Pt 10","key":"3578_CR1","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/brain\/awm212","volume":"130","author":"C Godfrey","year":"2007","unstructured":"Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain. 2007;130(Pt 10):2725\u201335.","journal-title":"Brain"},{"issue":"3","key":"3578_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/cge.13886","volume":"99","author":"D Song","year":"2021","unstructured":"Song D, Dai Y, Chen X, Fu X, Chang X, Wang N, et al. Genetic variations and clinical spectrum of dystroglycanopathy in a large cohort of Chinese patients. Clin Genet. 2021;99(3):384\u201395.","journal-title":"Clin Genet"},{"issue":"18","key":"3578_CR3","doi-asserted-by":"publisher","first-page":"15457","DOI":"10.1074\/jbc.R200031200","volume":"278","author":"DE Michele","year":"2003","unstructured":"Michele DE, Campbell KP. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem. 2003;278(18):15457\u201360.","journal-title":"J Biol Chem"},{"issue":"1","key":"3578_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jdn.10233","volume":"83","author":"X Zhao","year":"2023","unstructured":"Zhao X, Gao C, Li L, Jiang L, Wei Y, Che F, et al. Clinical exome sequencing identifies novel compound heterozygous mutations of the POMT2 gene in patients with limb-girdle muscular dystrophy. Int J Dev Neurosci. 2023;83(1):23\u201330.","journal-title":"Int J Dev Neurosci"},{"issue":"8","key":"3578_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/glycob\/cwp066","volume":"19","author":"M Lommel","year":"2009","unstructured":"Lommel M, Strahl S. Protein O-mannosylation: conserved from bacteria to humans. Glycobiology. 2009;19(8):816\u201328.","journal-title":"Glycobiology"},{"key":"3578_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mam.2016.07.003","volume":"51","author":"M Taniguchi-Ikeda","year":"2016","unstructured":"Taniguchi-Ikeda M, Morioka I, Iijima K, Toda T. Mechanistic aspects of the formation of alpha-dystroglycan and therapeutic research for the treatment of alpha-dystroglycanopathy: a review. Mol Aspects Med. 2016;51:115\u201324.","journal-title":"Mol Aspects Med"},{"issue":"5","key":"3578_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/jnnp-2017-317018","volume":"89","author":"ST Ostergaard","year":"2018","unstructured":"Ostergaard ST, Johnson K, Stojkovic T, Krag T, De Ridder W, De Jonghe P, et al. Limb girdle muscular dystrophy due to mutations in POMT2. J Neurol Neurosurg Psychiatry. 2018;89(5):506\u20135128.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3578_CR8","doi-asserted-by":"publisher","first-page":"692479","DOI":"10.3389\/fgene.2021.692479","volume":"12","author":"XY Chen","year":"2021","unstructured":"Chen XY, Song DY, Jiang L, Tan DD, Liu YD, Liu JY, et al. Phenotype and genotype study of Chinese POMT2-Related alpha-dystroglycanopathy. Front Genet. 2021;12:692479.","journal-title":"Front Genet"},{"issue":"4","key":"3578_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.bbrc.2007.09.066","volume":"363","author":"R Biancheri","year":"2007","unstructured":"Biancheri R, Falace A, Tessa A, Pedemonte M, Scapolan S, Cassandrini D, et al. POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes. Biochem Biophys Res Commun. 2007;363(4):1033\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3578_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.braindev.2023.01.010","volume":"45","author":"C Panicucci","year":"2023","unstructured":"Panicucci C, Casalini S, Damasio BM, Brolatti N, Pedemonte M, Biolcati Rinaldi A, et al. Long-term clinical and MRI follow-up in two POMT2-related limb girdle muscular dystrophy (LGMDR14) patients. Brain Dev. 2023;45(5):306\u201313.","journal-title":"Brain Dev"},{"issue":"9","key":"3578_CR11","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Gotz AW, Poole D, Le Grand S, Walker RC. Routine Microsecond Molecular Dynamics simulations with AMBER on GPUs. 2. Explicit Solvent particle Mesh Ewald. J Chem Theory Comput. 2013;9(9):3878\u201388.","journal-title":"J Chem Theory Comput"},{"issue":"16","key":"3578_CR12","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701\u201318.","journal-title":"J Comput Chem"},{"key":"3578_CR13","doi-asserted-by":"publisher","first-page":"1059322","DOI":"10.3389\/fgene.2023.1059322","volume":"14","author":"L Liang","year":"2023","unstructured":"Liang L, Wu H, Cai Z, Zhao J. Molecular dynamics and minigene assay of new splicing variant c.4298-20T\u2009>\u2009A of COL4A5 gene that cause Alport syndrome. Front Genet. 2023;14:1059322.","journal-title":"Front Genet"},{"key":"3578_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cca.2022.06.005","volume":"532","author":"R Zhang","year":"2022","unstructured":"Zhang R, Hao Y, Xu Y, Qin J, Wang Y, Kumar Dey S, et al. Whole exome sequencing identified a homozygous novel mutation in SUOX gene causes extremely rare autosomal recessive isolated sulfite oxidase deficiency. Clin Chim Acta. 2022;532:115\u201322.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"3578_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/jcmm.13979","volume":"23","author":"Y Dai","year":"2019","unstructured":"Dai Y, Liang S, Dong X, Zhao Y, Ren H, Guan Y, et al. Whole exome sequencing identified a novel DAG1 mutation in a patient with rare, mild and late age of onset muscular dystrophy-dystroglycanopathy. J Cell Mol Med. 2019;23(2):811\u20138.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"3578_CR16","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/jcmm.14768","volume":"24","author":"P Han","year":"2020","unstructured":"Han P, Wei G, Cai K, Xiang X, Deng WP, Li YB, et al. Identification and functional characterization of mutations in LPL gene causing severe hypertriglyceridaemia and acute pancreatitis. J Cell Mol Med. 2020;24(2):1286\u201399.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"3578_CR17","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/jcmm.14887","volume":"24","author":"R Zhang","year":"2020","unstructured":"Zhang R, Chen S, Han P, Chen F, Kuang S, Meng Z, et al. Whole exome sequencing identified a homozygous novel variant in CEP290 gene causes Meckel syndrome. J Cell Mol Med. 2020;24(2):1906\u201316.","journal-title":"J Cell Mol Med"},{"key":"3578_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jmgm.2016.06.001","volume":"68","author":"G Perez-Rodriguez","year":"2016","unstructured":"Perez-Rodriguez G, Perez-Perez M, Fdez-Riverola F, Lourenco A. High performance computing for three-dimensional agent-based molecular models. J Mol Graph Model. 2016;68:68\u201377.","journal-title":"J Mol Graph Model"},{"issue":"12","key":"3578_CR19","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/jmg.2005.031963","volume":"42","author":"J van Reeuwijk","year":"2005","unstructured":"van Reeuwijk J, Janssen M, van den Elzen C, Beltran-Valero de Bernabe D, Sabatelli P, Merlini L, et al. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet. 2005;42(12):907\u201312.","journal-title":"J Med Genet"},{"issue":"Pt 2","key":"3578_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/brain\/awr357","volume":"135","author":"L Devisme","year":"2012","unstructured":"Devisme L, Bouchet C, Gonzales M, Alanio E, Bazin A, Bessieres B, et al. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. Brain. 2012;135(Pt 2):469\u201382.","journal-title":"Brain"},{"key":"3578_CR21","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","DOI":"10.1038\/gim.2015.30"},{"issue":"4","key":"3578_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbrc.2011.07.012","volume":"411","author":"K Akasaka-Manya","year":"2011","unstructured":"Akasaka-Manya K, Manya H, Hayashi M, Endo T. Different roles of the two components of human protein O-mannosyltransferase, POMT1 and POMT2. Biochem Biophys Res Commun. 2011;411(4):721\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3578_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/jb\/mvp170","volume":"147","author":"H Manya","year":"2010","unstructured":"Manya H, Akasaka-Manya K, Nakajima A, Kawakita M, Endo T. Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2. J Biochem. 2010;147(3):337\u201344.","journal-title":"J Biochem"},{"issue":"7","key":"3578_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.tig.2020.11.002","volume":"37","author":"F Supek","year":"2021","unstructured":"Supek F, Lehner B, Lindeboom RGH. To NMD or not to NMD: nonsense-mediated mRNA decay in Cancer and Other Genetic diseases. Trends Genet. 2021;37(7):657\u201368.","journal-title":"Trends Genet"},{"issue":"4","key":"3578_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejmg.2008.12.004","volume":"52","author":"A Yanagisawa","year":"2009","unstructured":"Yanagisawa A, Bouchet C, Quijano-Roy S, Vuillaumier-Barrot S, Clarke N, Odent S, et al. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation. Eur J Med Genet. 2009;52(4):201\u20136.","journal-title":"Eur J Med Genet"},{"issue":"7","key":"3578_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.nmd.2008.04.004","volume":"18","author":"S Messina","year":"2008","unstructured":"Messina S, Mora M, Pegoraro E, Pini A, Mongini T, D\u2019Amico A, et al. POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study. Neuromuscul Disord. 2008;18(7):565\u201371.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"3578_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13395-018-0170-1","volume":"8","author":"K Johnson","year":"2018","unstructured":"Johnson K, Bertoli M, Phillips L, Topf A, Van den Bergh P, Vissing J, et al. Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness. Skelet Muscle. 2018;8(1):23.","journal-title":"Skelet Muscle"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03578-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:43:37Z","timestamp":1742301817000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03578-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03578-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients for the use of clinical information and materials in this research. This study was approved by the Ethics Committee of Qilu Hospital of Shandong University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients in our study signed consent for publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}